INC Research quick facts

• Top-tier, therapeutically focused CRO headquartered in Raleigh, N.C.
• Clinical development services from conception to commercialization
• More than 80 clinical development locations in 37 countries spanning six continents
• Approximately 5,000 employees worldwide
• Experience in more than 100 countries
• Customers include 46 of the world’s top 50 biopharmaceutical companies
• Contributed to the development of 19 of the top 20 selling medicines on the market today

A powerful global force in clinical development
INC Research is a leading global CRO providing Phase I to IV clinical development services. Our global scale, broad therapeutic expertise and commitment to operational excellence using our proven Trusted Process® allow us to develop innovative and flexible strategic alliances. By sharing incentives, dedicating resources, standardizing processes and customizing reporting, we save our customers time and money, freeing them to think about the next big thing. Such alliances have helped us contribute to the development of 19 of the top 20 selling medicines on the market today.

Global reach, local presence
The complexity of today’s large global trials means you need a CRO with the critical mass to deliver any study, anywhere. Our vast global network enables us to do just that. As well as providing access to international patient populations, this network also ensures ideas and innovations are shared across continents, demographic patterns are matched and the benefits of emerging markets are leveraged.

Broad therapeutic expertise
Our extensive expertise covers more than 90 percent of drugs in development today, including those for central nervous system (CNS), oncology, cardiovascular, endocrine, respiratory, and infectious diseases. We believe such expertise is so important that we’ve structured our entire organization around it, dedicating highly experienced business leaders as therapeutic heads to guide your strategies.

Operational excellence
Since 2006, INC Research has conducted all trials using our Trusted Process® – a methodology that reduces variability and increases trial outcome predictability by standardizing operational and quality controls. This allows us to deliver studies on time and on budget, without compromised data quality. Trials completed using this process report:

• Study start-up times three weeks faster than the industry average
• Patient enrolment completion three weeks quicker than originally planned
• 35 percent improvement in database lock times

Core services

• Biometrics
• Clinical data management
• Cognitive services
• Contracts and functional services
• Data integration and warehousing
• Drug safety
• Interactive voice response systems and international normalized ratio
• Medical monitoring
• Medical writing
• Patient recruitment and retention
• Project management
• Quality assurance
• Regulatory affairs
• Strategic consulting
• Study monitoring

Awards

2011: Winner of the Data Driven Innovation Award from the Society for Clinical Data Management

2011: Rated one of the world’s top CROs in the CenterWatch Global Investigative Site Survey

2009: Trusted Process® thought leaders named winners at the Clinical Research Excellence Awards